ArticlePloS one2024

Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample.

Karen M Stockl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.